Redhill Biopharma (RDHL) Competitors $1.83 +0.01 (+0.55%) Closing price 04:00 PM EasternExtended Trading$1.83 0.00 (0.00%) As of 06:56 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsFDA EventsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock RDHL vs. RNTX, KZR, XCUR, PASG, MIRA, ENLV, MBRX, FBLG, RVPH, and QTTBShould you be buying Redhill Biopharma stock or one of its competitors? The main competitors of Redhill Biopharma include Rein Therapeutics (RNTX), Kezar Life Sciences (KZR), Exicure (XCUR), Passage Bio (PASG), MIRA Pharmaceuticals (MIRA), Enlivex Therapeutics (ENLV), Moleculin Biotech (MBRX), FibroBiologics (FBLG), Reviva Pharmaceuticals (RVPH), and Q32 Bio (QTTB). These companies are all part of the "pharmaceutical products" industry. Redhill Biopharma vs. Its Competitors Rein Therapeutics Kezar Life Sciences Exicure Passage Bio MIRA Pharmaceuticals Enlivex Therapeutics Moleculin Biotech FibroBiologics Reviva Pharmaceuticals Q32 Bio Redhill Biopharma (NASDAQ:RDHL) and Rein Therapeutics (NASDAQ:RNTX) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their media sentiment, valuation, analyst recommendations, earnings, risk, institutional ownership, profitability and dividends. Which has better earnings & valuation, RDHL or RNTX? Redhill Biopharma has higher revenue and earnings than Rein Therapeutics. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioRedhill Biopharma$8.04M0.76-$8.27MN/AN/ARein TherapeuticsN/AN/A-$62.88M-$2.69-0.51 Do analysts recommend RDHL or RNTX? Rein Therapeutics has a consensus target price of $10.00, indicating a potential upside of 629.93%. Given Rein Therapeutics' stronger consensus rating and higher probable upside, analysts plainly believe Rein Therapeutics is more favorable than Redhill Biopharma.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Redhill Biopharma 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00Rein Therapeutics 1 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00 Is RDHL or RNTX more profitable? Redhill Biopharma's return on equity of 0.00% beat Rein Therapeutics' return on equity.Company Net Margins Return on Equity Return on Assets Redhill BiopharmaN/A N/A N/A Rein Therapeutics N/A -141.11%-33.83% Does the media favor RDHL or RNTX? In the previous week, Redhill Biopharma and Redhill Biopharma both had 3 articles in the media. Redhill Biopharma's average media sentiment score of 0.63 equaled Rein Therapeutics'average media sentiment score. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Redhill Biopharma 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Rein Therapeutics 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has more volatility and risk, RDHL or RNTX? Redhill Biopharma has a beta of 4.57, meaning that its share price is 357% more volatile than the S&P 500. Comparatively, Rein Therapeutics has a beta of 1.14, meaning that its share price is 14% more volatile than the S&P 500. Do insiders and institutionals have more ownership in RDHL or RNTX? 7.2% of Redhill Biopharma shares are held by institutional investors. Comparatively, 90.9% of Rein Therapeutics shares are held by institutional investors. 6.8% of Redhill Biopharma shares are held by company insiders. Comparatively, 5.1% of Rein Therapeutics shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth. SummaryRedhill Biopharma beats Rein Therapeutics on 6 of the 10 factors compared between the two stocks. Get Redhill Biopharma News Delivered to You Automatically Sign up to receive the latest news and ratings for RDHL and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding RDHL and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart RDHL vs. The Competition Export to ExcelMetricRedhill BiopharmaMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$6.06M$2.65B$6.14B$10.65BDividend YieldN/A56.72%5.66%4.70%P/E RatioN/A23.7585.8427.65Price / Sales0.76782.81626.36141.34Price / CashN/A177.3038.3262.20Price / Book-0.505.6413.066.79Net Income-$8.27M$32.78M$3.30B$275.88M7 Day Performance-17.57%6.31%4.81%2.64%1 Month Performance28.87%13.80%9.99%9.13%1 Year Performance-77.32%2.75%85.28%35.89% Redhill Biopharma Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)RDHLRedhill BiopharmaN/A$1.83+0.5%N/A-77.3%$6.06M$8.04M0.00210Analyst ForecastRNTXRein Therapeutics3.1736 of 5 stars$1.17+1.3%$10.00+758.4%N/A$27.16MN/A-0.439News CoverageAnalyst ForecastKZRKezar Life Sciences3.9415 of 5 stars$3.71+3.5%$9.00+142.3%-44.2%$26.97M$7M-0.3860Analyst ForecastXCURExicure1.6895 of 5 stars$4.16+6.5%N/A+104.6%$26.25M$500K-1.0750Analyst ForecastPASGPassage Bio3.644 of 5 stars$8.27+1.6%$75.67+815.0%-32.4%$26.08MN/A-0.45130Positive NewsAnalyst ForecastMIRAMIRA Pharmaceuticals1.0151 of 5 stars$1.33-0.4%N/A+20.0%$25.27MN/A-2.702Analyst ForecastENLVEnlivex Therapeutics2.9065 of 5 stars$1.04+2.5%$10.00+866.2%-22.0%$25.02MN/A-1.7870Analyst ForecastMBRXMoleculin Biotech3.0911 of 5 stars$0.50+2.7%$4.00+700.0%-79.7%$24.80MN/A0.0020Analyst ForecastFBLGFibroBiologics2.4489 of 5 stars$0.58-4.6%$12.67+2,068.9%-81.6%$24.46MN/A-1.6210Analyst ForecastRVPHReviva Pharmaceuticals3.7075 of 5 stars$0.36+16.1%$4.86+1,256.7%-42.0%$23.92MN/A-0.535Analyst ForecastGap UpHigh Trading VolumeQTTBQ32 Bio3.0144 of 5 stars$1.95+0.5%$12.17+523.9%-93.3%$23.79M$1.16M-0.4539News CoverageGap Up Related Companies and Tools Related Companies Rein Therapeutics Competitors Kezar Life Sciences Competitors Exicure Competitors Passage Bio Competitors MIRA Pharmaceuticals Competitors Enlivex Therapeutics Competitors Moleculin Biotech Competitors FibroBiologics Competitors Reviva Pharmaceuticals Competitors Q32 Bio Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:RDHL) was last updated on 10/9/2025 by MarketBeat.com Staff From Our PartnersMagnificent 7 being replaced by the “Hidden 7”?BULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredAn $8 trillion-dollar discovery 17,000 ft underwater A strange rock pulled from the ocean floor may hold the key to a $16 trillion resource boom. Inside it: materi...Porter & Company | SponsoredFront-Run Buffett's Shocking Gold MoveA Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | Sponsored2013 miner reveals his trading systemWhile everyone else is gambling on meme coins or chasing the next "100x moonshot," our members are systematica...Crypto Swap Profits | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredThe Tiny Stock Set to Soar with Musk's AI AmbitionsThe Tiny Stock Set to Soar with Musk's AI Ambitions While Musk builds one of the most ambitious AI empires ...Behind the Markets | SponsoredForget AI, This Will Be the Next Big Tech BreakthroughAfter picking Nvidia in 2016, before it jumped 27,000%... Jeff Brown is back with what he believes will be ...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Redhill Biopharma Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Redhill Biopharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
